El Salvador Achieves Historic Validation from WHO for Eliminating Trachoma as a Public Health Problem, Marking a Milestone in Global Health Efforts

The World Health Organization (WHO) has officially validated El Salvador as having successfully eliminated trachoma as a public health problem, a significant triumph against the world’s leading infectious cause of blindness. This landmark achievement positions El Salvador as the first country in Central America and only the second in the Americas to reach this milestone, underscoring the profound impact of sustained political commitment, strategic investment, and robust community engagement in public health initiatives. The validation follows a rigorous, multi-year process of assessment and verification, confirming that the debilitating eye disease no longer poses a public health threat within the nation’s borders.

Understanding Trachoma: The Silent Scourge of Blindness

Trachoma, a neglected tropical disease (NTD), is a bacterial infection caused by Chlamydia trachomatis. It is highly contagious and spreads through direct contact with ocular and nasal discharges of infected individuals, often via contaminated fingers, clothing, or eye-seeking flies. The disease typically begins in childhood, with repeated infections over many years leading to severe, irreversible consequences.

The initial stage, known as trachomatous inflammation – follicular (TF), manifests as inflammation of the inner eyelid. Without intervention, recurrent infections cause the inner eyelid to scar, leading to a condition called trachomatous trichiasis (TT). In TT, the eyelashes turn inward and constantly abrade the cornea, causing intense pain, corneal opacities, and ultimately, irreversible blindness. Globally, millions of people remain at risk of trachoma, with over 1.9 million individuals suffering from blindness or visual impairment due to the disease. The vast majority of those affected live in impoverished communities with limited access to clean water, sanitation, and adequate healthcare, perpetuating a vicious cycle of poverty and disease. Women, who often bear the primary responsibility for childcare and household duties, are disproportionately affected by TT and blindness. The socioeconomic burden of trachoma is immense, impacting productivity, education, and overall quality of life, effectively trapping communities in a cycle of marginalization.

A Global Commitment: The Fight Against Trachoma

The global health community has long recognized the devastating impact of trachoma. In 1996, WHO launched the Alliance for the Global Elimination of Trachoma by 2020 (GET2020), a collaborative network of governments, non-governmental organizations, and academic institutions dedicated to eradicating the disease. The alliance championed the SAFE strategy, a comprehensive public health approach comprising:

• Surgery for trichiasis (TT) to prevent blindness.
• Antibiotics (typically mass drug administration of azithromycin) to treat active infection.
• Facial cleanliness to reduce transmission.
• Environmental improvements, particularly access to clean water, sanitation, and hygiene (WASH), to prevent reinfection.

This strategy has been instrumental in driving progress worldwide. The target for global elimination was later extended to 2030 under the WHO’s "Road map for neglected tropical diseases 2021–2030," which outlines ambitious goals for the control, elimination, and eradication of over 30 communicable diseases and related conditions. In the Americas, the Pan American Health Organization (PAHO) has been a steadfast leader through its Disease Elimination Initiative, aiming to eliminate these conditions across the region by 2030. Trachoma was identified as a critical target within this broader initiative, with PAHO providing crucial technical and operational support to member states.

El Salvador’s Proactive Pathway to Eradication

El Salvador’s journey to trachoma elimination is a testament to its proactive and integrated public health strategy. Historically, El Salvador was among several countries in the Americas where the epidemiological status of trachoma was either unknown or suspected, necessitating comprehensive investigation. Other nations in the region where trachoma remains a public health problem include rural and remote areas of Brazil, Colombia, Guatemala, and Peru. Furthermore, countries like the Plurinational State of Bolivia, Ecuador, Guyana, Panama, Paraguay, and the Bolivarian Republic of Venezuela have expanded regional efforts to investigate and better define the disease’s status.

The validation process in El Salvador was meticulously conducted, spanning several years and culminating in a comprehensive review. Between 2023 and 2026, the country undertook targeted assessments in communities identified based on specific environmental and social risk factors that typically correlate with trachoma prevalence. These assessments involved extensive field surveys, clinical examinations, and data analysis. Crucially, no evidence of active trachoma transmission was found in children aged 1-9 years, the age group most susceptible to active infection. Furthermore, no advanced cases of trichiasis capable of causing blindness were detected in adults aged 15 years and older. These findings were pivotal in confirming that trachoma no longer constituted a public health problem within the nation.

El Salvador’s success was not achieved in isolation but through a robust multisectoral approach. The government significantly strengthened its primary health care services, ensuring broader access to basic medical attention, including early diagnosis and treatment for various conditions. Concurrent improvements in water, sanitation, and hygiene (WASH) infrastructure and practices played a vital role in breaking the chain of transmission. This included initiatives to provide safe drinking water, improve sanitation facilities, and promote hygiene education at the community level. Eye health services were also enhanced, with visual acuity screening integrated into adult health checks, ensuring that any potential cases of ocular disease could be identified and managed promptly. Collaboration was a cornerstone of this effort, involving various government sectors, local communities, and international partners, particularly PAHO through its Initiative for the Elimination of Trachoma in the Americas, and the generous support of the Government of Canada.

Moreover, El Salvador has proactively established sustainable systems to safeguard this achievement. This includes the training of health personnel to detect and manage potential future cases, the implementation of integrated surveillance mechanisms to monitor for any re-emergence of the disease, and the capacity to provide surgical interventions for trichiasis within the national health system. These measures ensure that the country remains vigilant and responsive, preventing any potential resurgence of the infection.

Statements and Reflections on a Collective Victory

The validation has been met with widespread commendation from global health leaders, recognizing the profound significance of El Salvador’s accomplishment.

Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, lauded the nation’s efforts, stating, "I congratulate El Salvador on this remarkable achievement. It is a testament to the power of political commitment, strategic investment, and community engagement. El Salvador’s success is a vital step towards our global target of eliminating trachoma worldwide by 2030 and a clear signal that a healthier, more equitable future is within reach." His words underscore the global implications of this success, serving as an inspiring precedent for other endemic countries striving towards the 2030 elimination target.

Dr. Jarbas Barbosa, Director of the Pan American Health Organization (PAHO), echoed this sentiment, emphasizing the country’s dedication to its most vulnerable populations. "This validation reflects El Salvador’s commitment to reaching populations in the most vulnerable conditions and generating solid evidence to demonstrate that trachoma is not endemic in the country. It is the result of sustained efforts to reach communities, identify potential cases, and ensure no one was left behind." Dr. Barbosa’s statement highlights the equity-focused approach taken by El Salvador, ensuring that public health benefits extend to all segments of society, particularly those historically underserved.

El Salvador’s Minister of Health, Francisco Alabi, expressed immense pride in the national effort. "El Salvador has reached a major health milestone by achieving certification as a country free of trachoma, the result of sustained national efforts, with the support of the Pan American Health Organization and the Embassy of Canada. We are proud to have reached this achievement in just three years, positioning the country in the region and improving the visual health of our population." The Minister’s remarks underscore the efficiency and determination with which El Salvador pursued this goal, showcasing a rapid trajectory towards elimination.

Broader Implications and a Healthier Future for the Americas

El Salvador’s elimination of trachoma holds significant implications, both regionally and globally. As the first country in Central America and the second in the Americas to achieve this status (after Mexico), it serves as a powerful beacon of hope and a practical model for other nations in the region still battling the disease. Its success demonstrates that with strategic planning, dedicated resources, and strong partnerships, even deeply entrenched public health problems can be overcome. This achievement is expected to galvanize efforts in Brazil, Colombia, Guatemala, Peru, and other countries in the Americas where trachoma remains a concern.

Furthermore, El Salvador now joins a distinguished group of 32 other countries validated by WHO for eliminating trachoma, including Algeria, Australia, Benin, Burundi, Cambodia, China, Egypt, Fiji, Gambia, Ghana, India, Iraq, Islamic Republic of Iran, Lao People’s Democratic Republic, Libya, Malawi, Mali, Mauritania, Mexico, Morocco, Myanmar, Nepal, Oman, Pakistan, Papua New Guinea, Saudi Arabia, Senegal, Togo, Tunisia, Vanuatu, and Viet Nam. This expanding list offers tangible proof that the global goal of eliminating trachoma by 2030 is increasingly within reach.

Beyond trachoma, El Salvador’s validation also places it among 64 countries worldwide that have been recognized by WHO for eliminating at least one neglected tropical disease, with seven of these countries located in the Americas. This broader achievement signifies a growing momentum in the global fight against NTDs, which disproportionately affect the poorest and most vulnerable communities, perpetuating cycles of poverty and ill-health. The elimination process itself often creates opportunities to deliver integrated health services, as seen in El Salvador, strengthening overall health systems and improving access to care for other conditions.

While celebrating this monumental success, WHO recommends that countries that have achieved elimination maintain robust surveillance systems and ensure continued access to quality eye care services. This vigilance is crucial to prevent the re-emergence of the disease, especially given the potential for imported cases and the dynamic nature of public health challenges. El Salvador’s commitment to these sustained measures will be vital in safeguarding its hard-won achievement.

In conclusion, El Salvador’s elimination of trachoma is more than just a public health victory; it is a powerful affirmation of the potential for collective action to transform lives. It stands as a testament to the efficacy of the SAFE strategy, the dedication of health workers, the resilience of communities, and the indispensable role of international collaboration. This milestone contributes significantly to the global vision of a healthier, more equitable future, free from the preventable suffering caused by neglected tropical diseases.